BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

synagis Pages on BioPortfolio:

BIOPHARMA RSV Mab, rDNA (Synagis from MedImmune)
Synagis was the first monoclonal antibody product approved in the U.S. for an .... In late 1999, MedImmune received supplemental approval allowing Synagis ...
http://www.bioportfolio.com/BioPharma/BIOPHARMA_RSV_Mab_rDNA...

BioPortfolio Biotechnology BioNews : live article
The only significant product currently sold for RSV is Synagis, an expensive monoclonal antibody from MedImmune/Abbott, which had sales of $849 million in
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

Respiratory Syncytial Virus RSV A market yet to reach its full ...
The RSV market is currently dominated by MedImmune's Synagis, a prophylactic ... Due to its high costs though, Synagis is only prescribed to a very limited ...
http://www.bioportfolio.com/cgi-bin/acatalog/Respiratory_Syn...

BioPortfolio Biotechnology BioNews : live article
... regulatory affairs positions of increasing responsibility, including oversight of domestic and international activities for MedImmune's drug Synagis.
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - MedImmune
In 1998, the Company launched Synagis (palivizumab) in the United States for ... Synagis is the first monoclonal antibody approved for an infectious disease ...
http://www.bioportfolio.com/biocorporate/6860-MedImmune.html...

BioPortfolio.com - BioWeb Toxemia Preeclampsia Search
Company Overview Company History Grants/Community Ethics/Compliance Contact Information Locations/Directions Research Support Product Overview Synagis® ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Respiratory Syncytial Virus: Can antivirals make the grade?
The leading RSV product, MedImmune's monoclonal antibody Synagis, is indicated for the ... The success of Synagis also reflects the greater potential for ...
http://www.bioportfolio.com/news/datamonitor_58.htm...

BioPortfolio Bulletin - Research and Business Intelliegence
RSV Mab, rDNA (Synagis from MedImmune) · EPO rDNA Amgen · FDA Approvals. Buy: BIOPHARMA: Biopharmaceutical Products in the U.S. Market 3rd Edition ...
http://www.bioportfolio.co.uk/bulletin_63.htm...

BioPortfolio - Lonza Biologics Plc
Lonza Biologics plc announced today that MedImmune's Synagis™ . ... http://www. bioportfolio.com/search/Lonza_Biologics_SL1_4DX_d. ...
http://www.bioportfolio.com/search/Lonza_Biologics_Plc.html...

BioPortfolio's Approved Drugs News by Tradename - Sb to Sz
SYNAGIS · SYNALAR · SYNAREL · SYNCURINE · SYNERA · SYNERCID · SYNKAYVITE · SYNOPHYLATE · SYNOVALYTE · SYNTHROID · SYNTOCINON · SYPRINE. Search BioNews ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

Results from other life science and pharmaceutical sites:

MedImmune | Products | Synagis
Official pharmaceutical website includes links to consumer FAQ s and product label in pdf format.
http://www.medimmune.com/products/synagis/index.asp...

New Study in Journal of Pediatrics Suggests Synagis® (palivizumab ...
New Study in Journal of Pediatrics Suggests Synagis® (palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants.
http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/P...

08-MED-0666 Synagis Master v10 Inc
Each 50 mg single-dose vial of Synagis liquid solution contains 50 mg of Synagis , 1.9 mg of histidine, 0.06 mg of glycine, ...
http://www.medimmune.com/pdf/products/synagis_pi.pdf...

Synagis
Abbott Synagis (palivizumab) ... Synagis (palivizumab). Product information specific to a particular country is available at the Web site(s) below. ...
http://www.abbott.com/content/en_US/20.10.203:203/product/Pr...

MedImmune | Products | Synagis® (palivizumab) Package Insert
DESCRIPTION: Synagis® (palivizumab) is a humanized monoclonal antibody (IgG1 k) produced by recombinant DNA technology, directed to an epitope in the A ...
http://www.medimmune.com/products/bookmarks/synagis_pi.html...

Synagis - Product Availability
Synagis (palivizumab) - Product Availability. ... Synagis is marketed by Abbott in many countries around the world and is available in these locations. ...
http://www.abbott.com/global/url/content/en_US/20.10.430:430...

BILLING INSTRUCTIONS FOR SYNAGIS (STARTING WITH RSV SEASON 2007-2008)
Synagis is not considered medically necessary for infants with the following conditions for which he/she is not at increased ...
http://www.dhmh.state.md.us/mma/mpap/pdf/Synagis101306.pdf...

Synagis
Palivizumab (SynagisR). Monthly Dose. Directions. State Chronic Pulmonary Diagnosis or Gestational Risk Factor(s):. Actual Gestational Age ______ weeks
...
http://www.hsc.wvu.edu/sop/rdtp/forms/Synagis.htm...

Pediatric Synagis® Clinic
Pediatric specialists at Central DuPage Hospital provide convenient care for babies and young children who require therapy with Synagis® monoclonal antibody
...
http://www.cdh.org/ClinicalServices.aspx?id=9100...

Pediatric Advisor 2005.4: RSV and Synagis
Synagis is a medicine that helps prevent serious lung infections caused by RSV. Synagis is an antibody that is made using DNA technology. ...
http://www.med.umich.edu/1libr/pa/pa_rsvsynag_hhg.htm...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.